The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Blood Coagulants Market Outlook 2024

Global Blood Coagulants Market Outlook 2024

Publishing Date : Dec, 2021

License Type :
 

Report Code : 1635117

No of Pages : 102

Synopsis
Coagulation is the process, by which blood changes from a liquid to a gel, forming a blood clot. In general terms, coagulation is a process in which the blood forms clots to block and then heal a lesion/wound/cut and stop the bleeding.

The global Blood Coagulants market was valued at US$ 391.9 million in 2020 and is expected to reach US$ 628.6 million by the end of 2027, growing at a CAGR of 6.5% during 2021-2027.

This report focuses on Blood Coagulants volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Blood Coagulants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Blood Coagulants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Recombinant Coagulation Factor
  • Plasma Coagulation Factor

Segment by Sale Channel

  • Hospital
  • Pharmacy
  • Other

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Pfizer
  • Bayer
  • Novo Nordisk
  • Takeda
  • SOBI
  • Octapharma
  • CSL

Scope of the Blood Coagulants Market Report

Report Metric

Details

Report Name

Blood Coagulants Market

Market size in 2020

US$ 391.9 Million

The revenue forecast in 2027

US$ 628.6 Million

Growth Rate

CAGR of 6.5% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Blood Coagulants Market Overview
1.1 Product Overview and Scope of Blood Coagulants
1.2 Blood Coagulants Segment by Type
1.2.1 Global Blood Coagulants Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Recombinant Coagulation Factor
1.2.3 Plasma Coagulation Factor
1.3 Blood Coagulants Segment by Sale Channel
1.3.1 Global Blood Coagulants Sales Comparison by Sale Channel: (2021-2027)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Blood Coagulants Market Size Estimates and Forecasts
1.4.1 Global Blood Coagulants Revenue 2016-2027
1.4.2 Global Blood Coagulants Sales 2016-2027
1.4.3 Blood Coagulants Market Size by Region: 2016 Versus 2021 Versus 2027

2 Blood Coagulants Market Competition by Manufacturers
2.1 Global Blood Coagulants Sales Market Share by Manufacturers (2016-2021)
2.2 Global Blood Coagulants Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Blood Coagulants Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Blood Coagulants Manufacturing Sites, Area Served, Product Type
2.5 Blood Coagulants Market Competitive Situation and Trends
2.5.1 Blood Coagulants Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Blood Coagulants Players Market Share by Revenue
2.5.3 Global Blood Coagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Blood Coagulants Retrospective Market Scenario by Region
3.1 Global Blood Coagulants Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Blood Coagulants Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Blood Coagulants Market Facts & Figures by Country
3.3.1 North America Blood Coagulants Sales by Country
3.3.2 North America Blood Coagulants Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Blood Coagulants Market Facts & Figures by Country
3.4.1 Europe Blood Coagulants Sales by Country
3.4.2 Europe Blood Coagulants Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Blood Coagulants Market Facts & Figures by Region
3.5.1 Asia Pacific Blood Coagulants Sales by Region
3.5.2 Asia Pacific Blood Coagulants Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Blood Coagulants Market Facts & Figures by Country
3.6.1 Latin America Blood Coagulants Sales by Country
3.6.2 Latin America Blood Coagulants Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Blood Coagulants Market Facts & Figures by Country
3.7.1 Middle East and Africa Blood Coagulants Sales by Country
3.7.2 Middle East and Africa Blood Coagulants Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Blood Coagulants Historic Market Analysis by Type
4.1 Global Blood Coagulants Sales Market Share by Type (2016-2021)
4.2 Global Blood Coagulants Revenue Market Share by Type (2016-2021)
4.3 Global Blood Coagulants Price by Type (2016-2021)

5 Global Blood Coagulants Historic Market Analysis by Sale Channel
5.1 Global Blood Coagulants Sales Market Share by Sale Channel (2016-2021)
5.2 Global Blood Coagulants Revenue Market Share by Sale Channel (2016-2021)
5.3 Global Blood Coagulants Price by Sale Channel (2016-2021)

6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Blood Coagulants Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Blood Coagulants Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Blood Coagulants Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Blood Coagulants Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Corporation Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Blood Coagulants Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novo Nordisk Blood Coagulants Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Blood Coagulants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Takeda Blood Coagulants Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 SOBI
6.5.1 SOBI Corporation Information
6.5.2 SOBI Description and Business Overview
6.5.3 SOBI Blood Coagulants Sales, Revenue and Gross Margin (2016-2021)
6.5.4 SOBI Blood Coagulants Product Portfolio
6.5.5 SOBI Recent Developments/Updates
6.6 Octapharma
6.6.1 Octapharma Corporation Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Blood Coagulants Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Octapharma Blood Coagulants Product Portfolio
6.6.5 Octapharma Recent Developments/Updates
6.7 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Blood Coagulants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CSL Blood Coagulants Product Portfolio
6.7.5 CSL Recent Developments/Updates

7 Blood Coagulants Manufacturing Cost Analysis
7.1 Blood Coagulants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Blood Coagulants
7.4 Blood Coagulants Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Blood Coagulants Distributors List
8.3 Blood Coagulants Customers

9 Blood Coagulants Market Dynamics
9.1 Blood Coagulants Industry Trends
9.2 Blood Coagulants Growth Drivers
9.3 Blood Coagulants Market Challenges
9.4 Blood Coagulants Market Restraints

10 Global Market Forecast
10.1 Blood Coagulants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Blood Coagulants by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Blood Coagulants by Type (2022-2027)
10.2 Blood Coagulants Market Estimates and Projections by Sale Channel
10.2.1 Global Forecasted Sales of Blood Coagulants by Sale Channel (2022-2027)
10.2.2 Global Forecasted Revenue of Blood Coagulants by Sale Channel (2022-2027)
10.3 Blood Coagulants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Blood Coagulants by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Blood Coagulants by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Blood Coagulants Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Blood Coagulants Sales (K Units) Comparison by Sale Channel (2021-2027)
Table 3. Global Blood Coagulants Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Blood Coagulants Covered in This Study
Table 5. Global Blood Coagulants Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Blood Coagulants Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Blood Coagulants Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Blood Coagulants Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Blood Coagulants Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Blood Coagulants Manufacturing Sites and Area Served
Table 11. Manufacturers Blood Coagulants Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Blood Coagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Coagulants as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Blood Coagulants Sales by Region (2016-2021) & (K Units)
Table 16. Global Blood Coagulants Sales Market Share by Region (2016-2021)
Table 17. Global Blood Coagulants Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Blood Coagulants Sales by Country (2016-2021) & (K Units)
Table 19. North America Blood Coagulants Sales Market Share by Country (2016-2021)
Table 20. North America Blood Coagulants Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Blood Coagulants Revenue Market Share by Country (2016-2021)
Table 22. Europe Blood Coagulants Sales by Country (2016-2021) & (K Units)
Table 23. Europe Blood Coagulants Sales Market Share by Country (2016-2021)
Table 24. Europe Blood Coagulants Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Blood Coagulants Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Blood Coagulants Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Blood Coagulants Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Blood Coagulants Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Blood Coagulants Revenue Market Share by Region (2016-2021)
Table 30. Latin America Blood Coagulants Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Blood Coagulants Sales Market Share by Country (2016-2021)
Table 32. Latin America Blood Coagulants Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Blood Coagulants Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Blood Coagulants Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Blood Coagulants Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Blood Coagulants Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Blood Coagulants Revenue Market Share by Country (2016-2021)
Table 38. Global Blood Coagulants Sales (K Units) by Type (2016-2021)
Table 39. Global Blood Coagulants Sales Market Share by Type (2016-2021)
Table 40. Global Blood Coagulants Revenue (Million US$) by Type (2016-2021)
Table 41. Global Blood Coagulants Revenue Share by Type (2016-2021)
Table 42. Global Blood Coagulants Price (USD/Unit) by Type (2016-2021)
Table 43. Global Blood Coagulants Sales (K Units) by Sale Channel (2016-2021)
Table 44. Global Blood Coagulants Sales Market Share by Sale Channel (2016-2021)
Table 45. Global Blood Coagulants Revenue (Million US$) by Sale Channel (2016-2021)
Table 46. Global Blood Coagulants Revenue Share by Sale Channel (2016-2021)
Table 47. Global Blood Coagulants Price (USD/Unit) by Sale Channel (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Blood Coagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer Blood Coagulants Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Bayer Corporation Information
Table 54. Bayer Description and Business Overview
Table 55. Bayer Blood Coagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Bayer Blood Coagulants Product
Table 57. Bayer Recent Developments/Updates
Table 58. Novo Nordisk Corporation Information
Table 59. Novo Nordisk Description and Business Overview
Table 60. Novo Nordisk Blood Coagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Novo Nordisk Blood Coagulants Product
Table 62. Novo Nordisk Recent Developments/Updates
Table 63. Takeda Corporation Information
Table 64. Takeda Description and Business Overview
Table 65. Takeda Blood Coagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Takeda Blood Coagulants Product
Table 67. Takeda Recent Developments/Updates
Table 68. SOBI Corporation Information
Table 69. SOBI Description and Business Overview
Table 70. SOBI Blood Coagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. SOBI Blood Coagulants Product
Table 72. SOBI Recent Developments/Updates
Table 73. Octapharma Corporation Information
Table 74. Octapharma Description and Business Overview
Table 75. Octapharma Blood Coagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Octapharma Blood Coagulants Product
Table 77. Octapharma Recent Developments/Updates
Table 78. CSL Corporation Information
Table 79. CSL Description and Business Overview
Table 80. CSL Blood Coagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. CSL Blood Coagulants Product
Table 82. CSL Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Blood Coagulants Distributors List
Table 86. Blood Coagulants Customers List
Table 87. Blood Coagulants Market Trends
Table 88. Blood Coagulants Growth Drivers
Table 89. Blood Coagulants Market Challenges
Table 90. Blood Coagulants Market Restraints
Table 91. Global Blood Coagulants Sales Forecast by Type (2022-2027) & (K Units)
Table 92. Global Blood Coagulants Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Blood Coagulants Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Blood Coagulants Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Blood Coagulants Sales Forecast by Sale Channel (2022-2027) & (K Units)
Table 96. Global Blood Coagulants Sales Market Share Forecast by Sale Channel (2022-2027)
Table 97. Global Blood Coagulants Revenue Forecast by Sale Channel (2022-2027) & (US$ Million)
Table 98. Global Blood Coagulants Revenue Market Share Forecast by Sale Channel (2022-2027)
Table 99. Global Blood Coagulants Sales Forecast by Region (2022-2027) & (K Units)
Table 100. Global Blood Coagulants Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Blood Coagulants Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Blood Coagulants Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Blood Coagulants
Figure 2. Global Blood Coagulants Market Share by Type in 2020 & 2027
Figure 3. Recombinant Coagulation Factor Product Picture
Figure 4. Plasma Coagulation Factor Product Picture
Figure 5. Global Blood Coagulants Market Share by Sale Channel in 2020 & 2027
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Other
Figure 9. Global Blood Coagulants Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Blood Coagulants Market Size 2016-2027 (US$ Million)
Figure 11. Global Blood Coagulants Sales 2016-2027 (K Units)
Figure 12. Global Blood Coagulants Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Blood Coagulants Sales Share by Manufacturers in 2020
Figure 14. Global Blood Coagulants Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Blood Coagulants Players: Market Share by Revenue in 2020
Figure 16. Blood Coagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Blood Coagulants Sales Market Share by Region (2016-2021)
Figure 18. Global Blood Coagulants Sales Market Share by Region in 2020
Figure 19. Global Blood Coagulants Revenue Market Share by Region (2016-2021)
Figure 20. Global Blood Coagulants Revenue Market Share by Region in 2020
Figure 21. U.S. Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Blood Coagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Blood Coagulants by Type (2016-2021)
Figure 46. Sales Market Share of Blood Coagulants by Sale Channel (2016-2021)
Figure 47. Sales Market Share of Blood Coagulants by Sale Channel in 2020
Figure 48. Revenue Share of Blood Coagulants by Sale Channel (2016-2021)
Figure 49. Revenue Share of Blood Coagulants by Sale Channel in 2020
Figure 50. Manufacturing Cost Structure of Blood Coagulants
Figure 51. Manufacturing Process Analysis of Blood Coagulants
Figure 52. Blood Coagulants Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’